EMAMI LIMITED – Trademark Portfolio
Entity Type: 99
EMAMI LIMITED holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered and 4 are pending. Notable registered marks include CREME 21.
687 Anandapur,
E.M. Bypass, Kolkata 700107, West Bengal
Showing of trademarks Trademarks
Trademark Classifications
EMAMI LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does EMAMI LIMITED have?
EMAMI LIMITED has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 pending, 3 abandoned.
What trademark classes does EMAMI LIMITED file in?
EMAMI LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 30 (Staple Foods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are EMAMI LIMITED's most well-known trademarks?
EMAMI LIMITED's registered trademark portfolio includes well-known marks such as CREME 21. These are among 1 currently registered trademark in the portfolio.
What is EMAMI LIMITED's trademark registration success rate?
EMAMI LIMITED has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 4 applications are pending review.